Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Journal of the American Chemical Society|March 10, 2005
Synthesis of the potent immunostimulatory adjuvant QS-21APengfei Wang, Yong-Jae Kim, Mauricio Navarro-Villalobos, et al.
The New England Journal of Medicine|May 21, 1992
A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study GroupE J Lewis, L G Hunsicker, S P Lan, et al.
Pharmacology, Biochemistry, and Behavior|January 30, 2007
Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-mazeKathleen R Bailey, Maria N Pavlova, Alex D Rohde, et al.
Journal of the American Chemical Society|July 20, 2006
A non-oxidative approach toward chemically and electrochemically functionalizing Si(111)Rosemary D Rohde, Heather D Agnew, Woon-Seok Yeo, et al.
Journal of the American Chemical Society|September 7, 2006
Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21AapiYong-Jae Kim, Pengfei Wang, Mauricio Navarro-Villalobos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2000
Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study GroupS M Korbet, E J Lewis, M M Schwartz, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2007
Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behaviorHongkui Zeng, Brian A Schimpf, Alex D Rohde, et al.
Pageof 12